ciulla t - Search Results

Year	Number of Results
1986	1
1988	2
1989	2
1991	1
1994	1
1995	5
1996	6
1997	9
1998	7
1999	8
2000	9
2001	11
2002	10
2003	6
2004	8
2005	7
2006	3
2007	4
2008	2
2009	10
2010	12
2011	10
2012	7
2013	12
2014	10
2015	6
2016	5
2017	7
2018	9
2019	10
2020	16
2021	6

1

Innovative therapies for neovascular age-related macular degeneration.

Al-Khersan H, Hussain RM, Ciulla TA, Dugel PU. Al-Khersan H, et al. Among authors: ciulla ta. Expert Opin Pharmacother. 2019 Oct;20(15):1879-1891. doi: 10.1080/14656566.2019.1636031. Epub 2019 Jul 12. Expert Opin Pharmacother. 2019. PMID: 31298960 Review.

2

Complement inhibition as a therapeutic strategy in retinal disorders.

Kassa E, Ciulla TA, Hussain RM, Dugel PU. Kassa E, et al. Among authors: ciulla ta. Expert Opin Biol Ther. 2019 Apr;19(4):335-342. doi: 10.1080/14712598.2019.1575358. Epub 2019 Feb 11. Expert Opin Biol Ther. 2019. PMID: 30686077 Review.

3

Stargardt macular dystrophy and evolving therapies.

Hussain RM, Ciulla TA, Berrocal AM, Gregori NZ, Flynn HW Jr, Lam BL. Hussain RM, et al. Among authors: ciulla ta. Expert Opin Biol Ther. 2018 Oct;18(10):1049-1059. doi: 10.1080/14712598.2018.1513486. Epub 2018 Sep 10. Expert Opin Biol Ther. 2018. PMID: 30129371 Review.

4

Gene therapy for age-related macular degeneration.

Moore NA, Bracha P, Hussain RM, Morral N, Ciulla TA. Moore NA, et al. Among authors: ciulla ta. Expert Opin Biol Ther. 2017 Oct;17(10):1235-1244. doi: 10.1080/14712598.2017.1356817. Epub 2017 Jul 20. Expert Opin Biol Ther. 2017. PMID: 28726562 Review.

5

Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease.

Hussain RM, Neiweem AE, Kansara V, Harris A, Ciulla TA. Hussain RM, et al. Among authors: ciulla ta. Expert Opin Investig Drugs. 2019 Oct;28(10):861-869. doi: 10.1080/13543784.2019.1667333. Epub 2019 Sep 26. Expert Opin Investig Drugs. 2019. PMID: 31513439 Review.

6

Gene therapy for inherited retinal and optic nerve degenerations.

Moore NA, Morral N, Ciulla TA, Bracha P. Moore NA, et al. Among authors: ciulla ta. Expert Opin Biol Ther. 2018 Jan;18(1):37-49. doi: 10.1080/14712598.2018.1389886. Epub 2017 Oct 23. Expert Opin Biol Ther. 2018. PMID: 29057663 Review.

7

Ranibizumab and bevacizumab for neovascular age-related macular degeneration.

CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. CATT Research Group, et al. N Engl J Med. 2011 May 19;364(20):1897-908. doi: 10.1056/NEJMoa1102673. Epub 2011 Apr 28. N Engl J Med. 2011. PMID: 21526923 Free PMC article. Clinical Trial.

8

Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review.

Khanna S, Komati R, Eichenbaum DA, Hariprasad I, Ciulla TA, Hariprasad SM. Khanna S, et al. Among authors: ciulla ta. BMJ Open Ophthalmol. 2019 Dec 15;4(1):e000398. doi: 10.1136/bmjophth-2019-000398. eCollection 2019. BMJ Open Ophthalmol. 2019. PMID: 31909196 Free PMC article. Review.

9

Vascular dysfunction in retinitis pigmentosa.

Lang M, Harris A, Ciulla TA, Siesky B, Patel P, Belamkar A, Mathew S, Verticchio Vercellin AC. Lang M, et al. Among authors: ciulla ta. Acta Ophthalmol. 2019 Nov;97(7):660-664. doi: 10.1111/aos.14138. Epub 2019 May 17. Acta Ophthalmol. 2019. PMID: 31099494 Free article. Review.

10

Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration.

Hussain RM, Ciulla TA. Hussain RM, et al. Among authors: ciulla ta. Expert Opin Emerg Drugs. 2017 Sep;22(3):235-246. doi: 10.1080/14728214.2017.1362390. Epub 2017 Aug 4. Expert Opin Emerg Drugs. 2017. PMID: 28756707 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results